The Myers Lab, led by Daniel D. Myers, DVM, MPH, DACLAM, is developing new approaches to understanding and treating venous thrombosis. The formation of blood clots within a vessel can have deadly consequences, and the Myers Laboratory is investigating the processes involved in clot formation and new therapeutic interventions to inhibit them with fewer side effects. Our work is highly translational, with a goal to improve treatment — and prevention — for patients.
Our research mission is to improve the human condition by discovery through research on means to prevent, cure, and lessen the burden of vascular disease, and provide an arena to train DVM’s, M.D.’s, Ph.D.’s, medical and post-doctoral research fellows, clinicians, graduate students, and undergraduates alike. We are internationally recognized for our expertise in translational animal model development, and our research in this area is helping define the mechanisms underlying vascular disease and to evaluate new therapeutics. Through an NIH T32 training grant, the Jobst Pre-clinical group, as well as collaborations with the U-M Unit for Laboratory Animal Medicine, we also train future basic and surgical scientists through several novel programs for trainees at all levels.